Nanomedicine for brain cancer
CNS tumors remain among the deadliest forms of cancer, resisting conventional and new
treatment approaches, with mortality rates staying practically unchanged over the past 30 …
treatment approaches, with mortality rates staying practically unchanged over the past 30 …
Nanomedicine for brain cancer
S Quader, K Kataoka, H Cabral - Advanced drug delivery …, 2022 - pubmed.ncbi.nlm.nih.gov
CNS tumors remain among the deadliest forms of cancer, resisting conventional and new
treatment approaches, with mortality rates staying practically unchanged over the past 30 …
treatment approaches, with mortality rates staying practically unchanged over the past 30 …
[引用][C] Nanomedicine for brain cancer
S Quader, K Kataoka, H Cabral - Advanced Drug Delivery Reviews, 2022 - cir.nii.ac.jp
Nanomedicine for brain cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
Nanomedicine for brain cancer.
S Quader, K Kataoka, H Cabral - Advanced Drug Delivery Reviews, 2022 - europepmc.org
CNS tumors remain among the deadliest forms of cancer, resisting conventional and new
treatment approaches, with mortality rates staying practically unchanged over the past 30 …
treatment approaches, with mortality rates staying practically unchanged over the past 30 …